StockNews.com Downgrades Tactile Systems Technology (NASDAQ:TCMD) to Buy

Tactile Systems Technology (NASDAQ:TCMD) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Monday.

Several other research firms have also issued reports on TCMD. BTIG Research lowered shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research report on Tuesday, November 5th. B. Riley started coverage on shares of Tactile Systems Technology in a research note on Thursday, September 26th. They issued a “buy” rating and a $23.00 price objective for the company. Finally, Oppenheimer downgraded shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 5th.

Tactile Systems Technology Stock Performance

NASDAQ TCMD opened at $18.33 on Monday. The company has a current ratio of 4.37, a quick ratio of 3.80 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $439.87 million, a price-to-earnings ratio of 28.20 and a beta of 1.17. The firm’s 50 day simple moving average is $14.84 and its 200 day simple moving average is $13.39. Tactile Systems Technology has a 1 year low of $11.12 and a 1 year high of $21.10.

Hedge Funds Weigh In On Tactile Systems Technology

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Arcadia Investment Management Corp MI bought a new position in shares of Tactile Systems Technology during the third quarter valued at $29,000. Gladius Capital Management LP bought a new position in shares of Tactile Systems Technology during the third quarter valued at $44,000. Quarry LP bought a new position in shares of Tactile Systems Technology during the second quarter valued at $46,000. Magnetar Financial LLC bought a new position in shares of Tactile Systems Technology during the second quarter valued at $130,000. Finally, SG Americas Securities LLC bought a new position in shares of Tactile Systems Technology during the third quarter valued at $156,000. Institutional investors own 83.43% of the company’s stock.

Tactile Systems Technology Company Profile

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.